CFR Eyes Domestic Issue

CFR is expected to issue in Chile’s domestic bond market before the end of the year, assuming stable conditions, according to sources familiar with the Chilean pharmaceutical company’s plans. The issuer has registered an issuance of up to UF4m ($190m), with tranches of up to 10 and 30 years. It would be the Chilean pharmaceutical company’s first bond issuance. Proceeds could be used for planned M&A activity. IMTrust and Santander are managing. CFR is rated A+ on a national scale.